Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 183 results found. Search for [ Oxford corona vaccine ]

Results 80 to 100 of 183
BusinessToday.In
October 17, 2020
The shots planned for the initial phase would include a booster dose as well. The list comprises four categories of beneficiaries including frontline workers, healthcare professionals, people above 50, and people with comorbidities


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


BusinessToday.In
October 9, 2020
Bharat Biotech vaccine: The subject expert committee that discussed the matter in a meeting on October 5 has asked the company to resubmit the protocol and clarify the definition of asymptomatic


BusinessToday.In
October 8, 2020
Coronavirus vaccine update: The CDSCO panel said that safety and immunogenicity data from early-stage trials of the Russian vaccine Sputnik V that were conducted overseas had a small number of participants


BusinessToday.In
October 6, 2020
One of the causes attributed to the falling fresh positive cases is a natural fall in testing rates. Another reason is that the share of the Rapid Antigen Test vs the 'gold standard' PCR test has been rising


PTI
October 4, 2020
Health Minister Harsh Vardhan said a high-level expert group is going into all the aspects of vaccines and the health ministry is preparing a format in which states will submit lists of priority population groups


BusinessToday.In
October 4, 2020
COVID-19 vaccine update: The Centre is deliberating allowing companies to secure vaccine doses directly and early on to ensure that there is no disruption of key economic activities


BusinessToday.In
October 3, 2020
COVID-19 vaccine: A principal investigator from a trial site in Maharashtra said that they are expecting to finish enrolling the participants within the next two months after which they will be monitored for the vaccine's efficacy


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


Joe C Mathew
September 30, 2020
They state that access to means to fight COVID-19 on a global scale requires financial resources, assets, infrastructure, and jurisdictional support and collaboration beyond the capacity or role of each one of them


BusinessToday.In
New Delhi, September 23, 2020
Adar Poonawalla is the CEO of his family-owned company Serum Institute of India, which is the world's largest manufacturer of vaccines by volume. Poonawalla, who is in the spotlight in the global vaccine race for coronavirus, has promised to manufacture 400 million doses per month after the approval of the coronavirus vaccine. He has become the biggest hope for the global community during the pandemic. Serum Institute is currently conducting phase 3 clinical trials for the Oxford University-AstraZeneca vaccine. Here is all you need to know about the man himself and how he might prove to be our best bet during the pandemic. Watch the video for more.Also Read: Serum Institute to conduct clinical trials for Novavax COVID-19 vaccine


BusinessToday.In
September 23, 2020
This inoculation adds to Bharat Biotech's portfolio of vaccines currently being developed by it and are in several stages of clinical development, comprising COVAXIN- which is India's first indigenous vaccine against coronavirus


BusinessToday.In
September 22, 2020
Gagandeep Kang, professor of microbiology at Christian Medical College said that by year-end, data on which vaccine candidate is working and which not will be made available


BusinessToday.In
New Delhi, September 21, 2020
Farm bills passed in Rajya Sabha amid protests by opposition MPs; Tata Consultancy Services sets up 11 COVID-19 isolation centres for staff, dependents; DCGI nod to commercial launch of India's first low-cost COVID-19 test 'FELUDA'. Watch this and more news on News Blast.Also Read: Feluda: Satyajit Ray's iconic character who is now COVID-19 detective


BusinessToday.In
September 16, 2020
Besides, the drug regulating body of the country has told the Serum Institute to take extra care during screening, provide additional information in informed consent, and closely monitor participants for any adverse events during follow-up of the study


BusinessToday.In
September 15, 2020
India Stock Market Highlights Today: Titan, followed by Sun Pharma, HDFC, ICICI Bank, Bajaj Finance, NTPC, HDFC Bank and M&M were among the major gainers on Sensex pack today. On the other hand, Tech Mahindra, HCL Tech, Kotak Bank, ITC and Bharti Airtel were among the laggards


BusinessToday.In
September 14, 2020
The DCGI had issued a show-cause notice to Serum Institute of India on September 9 for not informing it about AstraZeneca pausing clinical trials of the vaccine candidate in other countries


BusinessToday.In
September 12, 2020
India's total recoveries recorded biggest single-day increase of 81,533 on Saturday; recovery rate has improved to highest level ever at 77.77 per cent


BusinessToday.In
September 11, 2020
Another leading candidate for coronavirus vaccine is Moderna. The company said that it is talking to multiple countries for the rollout of the COVID-19 vaccine.


Mail Today Bureau
September 11, 2020
Coronavirus update: The total number of deaths from COVID-19 rose to 76,271 after 1,209 deaths were reported in last 24 hours. The fatality rate has declined to 1.67 per cent


PAGES 5 OF 10  12345